Wells Fargo
APTO

Wells Fargo’s Aptose Biosciences, Inc. APTO Stock Holding History

Wells Fargo’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$18 – 7315
2024
Q3 		$23 Buy
+2
New +$30 ﹤0.01% 6524
2024
Q2 		– Sell
-2
Closed -$68 – 7762
2024
Q1 		$120 Hold
2
– – ﹤0.01% 6613
2023
Q4 		$117 Sell
2
-55
-96% -$4.27K ﹤0.01% 6724
2023
Q3 		$4.79K Hold
57
– – ﹤0.01% 5961
2023
Q2 		$7.94K Sell
57
-22
-28% -$4.55K ﹤0.01% 5961
2023
Q1 		$22.8K Hold
79
– – ﹤0.01% 5583
2022
Q4 		$20.7K Buy
79
+55
+229% +$14.8K ﹤0.01% 5248
2022
Q3 		$6K Hold
24
– – ﹤0.01% 5881
2022
Q2 		$8K Hold
24
– – ﹤0.01% 5865
2022
Q1 		$15K Hold
24
– – ﹤0.01% 6138
2021
Q4 		$15K Sell
24
-32
-57% -$30.1K ﹤0.01% 6426
2021
Q3 		$55K Buy
56
+48
+600% +$60K ﹤0.01% 5599
2021
Q2 		$12K Buy
8
+3
+60% +$6.54K ﹤0.01% 6095
2021
Q1 		$13K Buy
5
+3
+150% +$5.95K ﹤0.01% 6276
2020
Q4 		$3K Sell
2
-3
-60% -$7.05K ﹤0.01% 6248
2020
Q3 		$13K Sell
5
-10
-67% -$24.9K ﹤0.01% 5844
2020
Q2 		$43K Buy
15
+1
+7% +$3.23K ﹤0.01% 5534
2020
Q1 		$37K Buy
14
+12
+600% +$35.8K ﹤0.01% 5440
2019
Q4 		$4K Buy
+2
New +$2.61K ﹤0.01% 6092
2018
Q2 		– Sell
-2
Closed -$3K – 6658
2018
Q1 		$3K Buy
+2
New +$2.68K ﹤0.01% 6161

Other funds holding APTO

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's APTO Position: Q4 2024 in Review

Wells Fargo sold out of Aptose Biosciences, Inc. (APTO) in Q4 2024, closing a stake of 2 shares — an estimated $18 sold.

Wells Fargo first reported a position in APTO in Q1 2018 and held it in 20 quarters. The position peaked at $55K in Q3 2021. 22 funds tracked by Wall St. Rank hold APTO as of Q4 2024.

  • Wells Fargo reported no remaining Aptose Biosciences, Inc. position as of Q4 2024 after selling out during the quarter.
  • Wells Fargo sold 2 Aptose Biosciences, Inc. shares in Q4 2024, an estimated $18.
  • Wells Fargo first reported a position in Aptose Biosciences, Inc. in Q1 2018 and held it in 20 quarters.
  • Wells Fargo's Aptose Biosciences, Inc. position peaked at $55K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.